 speaker spotlight Giovanni Caforio, M.D.
Chairman and Chief Executive Officer of Bristol Myers Squibb
It is set to be a big year for BMS, with a new type of medicine in a category the company pioneered: checkpoint inhibitors that fight cancer by allowing the immune system to attack it. Giovanni Caforio joins STAT's Adam Feuerstein to talk about the company’s pipeline and research, the state of the pharmaceutical industry, and the need for diversity in clinical trials. GET TICKET You'll also hear from Pfizer's Annaliesa Anderson, SVP, chief scientific officer for bacterial vaccines and hospital and Charlotte Allerton, SVP, head of medicine design, about their work to develop Paxlovid, an effective oral drug to treat Covid-19. The full day event is packed with exciting and dynamic speakers, who are rethinking how science and medicine are developed and practiced, you won't want to miss a moment! Learn more about the STAT Summit speakers and their sessions, plus explore ticket options at statnews.com/summit.
How to join:
Purchase the Viewer Pass to unlock virtual access to program, and networking opportunities via our event platform. If you want to be a part of the in-person program and reception hosted in New York City, apply for the Attendee Pass at checkout. GET TICKET
Questions?
We can always be reached at summit@statnews.com. 
| 
No comments